Epithalon vs Semax
A comprehensive, data-driven comparison of Epithalon (Epitalon) and Semax. Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Epithalon Epitalon, Epithalone | Semax |
|---|---|---|
| FDA Status | Not submitted | Not submitted |
| Category | Anti-Aging | Cognitive Enhancement |
| Primary Use | Anti-aging and longevity research | Cognitive enhancement and neuroprotection |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $40 - $80/mo | $45 - $90/mo |
| Administration | Subcutaneous injection | Nasal spray |
| Typical Dose | 5-10mg per cycle (10-20 days, 2-3x per year) | 2-3 drops per nostril 2-3x daily |
| Frequency | Cyclical | Daily |
| Mechanism | Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend cellular lifespan | Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects neurons |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Emerging | Moderate |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Epithalon is generally more affordable ($40 - $80/mo) compared to Semax ($45 - $90/mo).
- 2Epithalon is administered via subcutaneous injection, while Semax uses nasal spray.
- 3Epithalon is dosed cyclical, while Semax is daily.
- 4Semax has moderate-quality evidence, while Epithalon has emerging-quality evidence.
- 5They belong to different categories: Epithalon (Anti-Aging) vs Semax (Cognitive Enhancement).
Which Is Better For...
Epithalon
More budget-friendly option with lower monthly costs
Epithalon
More convenient dosing schedule (cyclical)
Epithalon
Fewer commonly reported side effects
Semax
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Epithalon | $40 - $80/mo | Not submitted | Various research labs |
| Semax | $45 - $90/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Epithalon works via Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend. Semax works via Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects. They differ in FDA approval status, efficacy data, and cost.
Epithalon typically costs $40 - $80/mo, while Semax costs $45 - $90/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Epithalon is not FDA-approved (Not submitted). Semax is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Epithalon include Injection site reactions, Mild drowsiness, Vivid dreams. Common side effects of Semax include Nasal irritation, Mild stimulation, Headache. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched primarily in Russia for its potential anti-aging properties. The proposed mechanism involves activation of telomerase, an enzyme that...
View Full Epithalon GuideSemax is a synthetic peptide analog of adrenocorticotropic hormone (ACTH) developed in Russia. It has been shown to increase brain-derived neurotrophic factor (BDNF), improve cerebral blood flow, and ...
View Full Semax GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Epithalon and Semax should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.